Vir Biotechnology, Inc 10-Q for FY2022 Q3
Vir Biotechnology, Inc. (VIR)
10-Q
2022-11-03
For: 2022-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Vir Biotechnology, Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $374.56M
- up 261.5% from $103.62M a year earlier
- Net income
- $175.31M
- up 58.8% from net income of $110.43M a year earlier
- Diluted EPS
- $1.30
- up 58.5% from $0.82 a year earlier